Analyzing Good Businesses

Analyzing Good Businesses

Share this post

Analyzing Good Businesses
Analyzing Good Businesses
AGB 2022.10 - IQVIA (IQV)

AGB 2022.10 - IQVIA (IQV)

Improving Outsourced R&D

YoungHamilton's avatar
YoungHamilton
Aug 01, 2022
∙ Paid
26

Share this post

Analyzing Good Businesses
Analyzing Good Businesses
AGB 2022.10 - IQVIA (IQV)
9
Share

Subscribe to AGB - One analysis of a good business every three weeks.

IQVIA

IQVIA is the leading contract research organization (CRO) and data analytics provider for the life sciences industry. The company is the result of the 2016 merger between Quintiles, the leading CRO, and IMS Health, the leading clinical data provider for life science companies. The main thesis of the merger was that the business combination would allow for the leverage of data across both segments and introduce new products for its customers. The two most successful product introductions as a result of the merger are next generation clinical trials and real world evidence.

IQVIA has the largest dataset of anonymized health data with over 1.2B non-identified patient records and 56B petabytes of proprietary data coming over 150k data suppliers. Over 100B healthcare records are processed annually, adding to or supplementing the existing dataset. The company then sells access to the data to its customers or leverages …

This post is for subscribers in the Prime Supporter plan

Already in the Prime Supporter plan? Sign in
© 2025 YoungHamilton
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share